0001181431-13-040447.txt : 20130717 0001181431-13-040447.hdr.sgml : 20130717 20130717211307 ACCESSION NUMBER: 0001181431-13-040447 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130717 FILED AS OF DATE: 20130717 DATE AS OF CHANGE: 20130717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VERTICAL GROUP LP CENTRAL INDEX KEY: 0001180179 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 13973783 BUSINESS ADDRESS: STREET 1: 25 DEFOREST AVE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: 9082773737 MAIL ADDRESS: STREET 1: 25 DEFOREST AVE CITY: SUMMIT STATE: NJ ZIP: 07901 3 1 rrd385856.xml X0206 3 2013-07-17 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001180179 VERTICAL GROUP LP 25 DEFOREST AVE SUMMIT NJ 07901 0 0 1 0 Series A Preferred Stock 0 Class A Common Stock 473122 I See Footnote Series A Preferred Stock 0 Class A Common Stock 237403 I See Footnote Series B Preferred Stock 0 Class A Common Stock 547205 I See Footnote Series B Preferred Stock 0 Class A Common Stock 287527 I See Footnote Series B-1 Preferred Stock 0 Class A Common Stock 666661 I See Footnote Series B-1 Preferred Stock 0 Class A Common Stock 278764 I See Footnote Each share of Series A, Series B and Series B-1 Preferred Stock will automatically convert on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering. The securities are immediately convertible. The expiration date is not relevant to the conversion of these securities. The Class A Common Stock will be redesignated "Common Stock" immediately prior to the consummation of the Issuer's initial public offering. The shares are held directly by Vertical Fund I, L.P., ("VFI"), a Delaware limited partnership. The Vertical Group, L.P. ("VG LP"), a Delaware limited partnership, is the sole general partner of VFI, and The Vertical Group GP, LLC ("VG LLC"), a Delaware limited liability company, controls VG LP. VG LP and VG LLC disclaim beneficial ownership of all securities that may be deemed to be beneficially owned by VFI except to the extent of any pecuniary interest therein. This Form 3 shall not be deemed an admission that VG LP, VG LLC or any other person referred to herein is a beneficial owner of any securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. The shares are held directly by Vertical Fund II, L.P., ("VFII"), a Delaware limited partnership. The Vertical Group, L.P. ("VG LP"), a Delaware limited partnership, is the sole general partner of VFII, and The Vertical Group GP, LLC ("VG LLC"), a Delaware limited liability company, controls VG LP. VG LP and VG LLC disclaim beneficial ownership of all securities that may be deemed to be beneficially owned by VFII except to the extent of any pecuniary interest therein. This Form 3 shall not be deemed an admission that VG LP, VG LLC or any other person referred to herein is a beneficial owner of any securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. /s/ John E. Runnells, Authorized Signatory for The Vertical Group, L.P. 2013-07-17